Rapimig Orally Dispersible Tablets 2.5mg, 2 Tablets

Overview

Rapimig orally dispersible tablets contain the active ingredient zolmitriptan 2.5mg, designed for the acute care for migraine attacks. Each pack contains 2 tablets in a convenient blister format. Manufactured by Actavis Ltd., Malta, under the TEVA brand, these tablets dissolve quickly in the mouth without the need for water, offering ease of use during a migraine episode.

Zolmitriptan belongs to the triptan class of medications, which work by targeting serotonin receptors to help manage migraine symptoms. The orally dispersible form is particularly suitable for individuals who may experience nausea or difficulty swallowing during an attack. Always follow the usage instructions provided by your healthcare professional.

Why You'll Like It

• Orally dispersible formulation dissolves quickly without water
• Compact pack of 2 tablets for on-the-go use
• Manufactured by a reputable pharmaceutical company under the TEVA brand
• Active ingredient zolmitriptan is widely used for migraine care
• Easy-to-carry blister packaging

Who It's For

• Individuals seeking a fast-dissolving migraine medication
• Those who prefer not to swallow tablets during a migraine attack
• Buyers looking for a small pack size for occasional use
• People who need a portable option for migraine relief on the go

Package Details

• Pack size: 2 tablets
• Form: Orally dispersible tablets
• Strength: 2.5mg each
• Manufacturer: Actavis Ltd., Malta

Common Questions